These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1238 related items for PubMed ID: 26781152

  • 41. Implementation of FAST-PET/MRI for whole-body staging of female patients with recurrent pelvic malignancies: A comparison to PET/CT.
    Grueneisen J, Schaarschmidt BM, Heubner M, Suntharalingam S, Milk I, Kinner S, Heubner A, Forsting M, Lauenstein T, Ruhlmann V, Umutlu L.
    Eur J Radiol; 2015 Nov; 84(11):2097-102. PubMed ID: 26321491
    [Abstract] [Full Text] [Related]

  • 42. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia.
    Zhou WL, Wu HB, Wang LJ, Tian Y, Dong Y, Wang QS.
    Eur J Radiol; 2016 Jan; 85(1):205-210. PubMed ID: 26724667
    [Abstract] [Full Text] [Related]

  • 43. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
    Schaarschmidt BM, Heusch P, Buchbender C, Ruhlmann M, Bergmann C, Ruhlmann V, Schlamann M, Antoch G, Forsting M, Wetter A.
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
    [Abstract] [Full Text] [Related]

  • 44. Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.
    Partovi S, Kohan A, Vercher-Conejero JL, Rubbert C, Margevicius S, Schluchter MD, Gaeta C, Faulhaber P, Robbin MR.
    AJNR Am J Neuroradiol; 2014 Oct; 35(10):1970-5. PubMed ID: 24924545
    [Abstract] [Full Text] [Related]

  • 45. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
    Schmidt GP, Baur-Melnyk A, Haug A, Heinemann V, Bauerfeind I, Reiser MF, Schoenberg SO.
    Eur J Radiol; 2008 Jan; 65(1):47-58. PubMed ID: 18082989
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
    Squillaci E, Manenti G, Mancino S, Cicciò C, Calabria F, Danieli R, Schillaci O, Simonetti G.
    Abdom Imaging; 2008 Jan; 33(6):676-88. PubMed ID: 18373114
    [Abstract] [Full Text] [Related]

  • 49. Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image quality.
    Iagaru A, Mittra E, Minamimoto R, Jamali M, Levin C, Quon A, Gold G, Herfkens R, Vasanawala S, Gambhir SS, Zaharchuk G.
    Clin Nucl Med; 2015 Jan; 40(1):1-8. PubMed ID: 25489952
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S, Heusner T, Kümmel S, Köninger A, Nagarajah J, Müller S, Boy C, Forsting M, Bockisch A, Antoch G, Stahl A.
    Acta Radiol; 2011 Nov 01; 52(9):1009-14. PubMed ID: 21969709
    [Abstract] [Full Text] [Related]

  • 52. Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values.
    Sasaki M, Tozaki M, Kubota K, Murakami W, Yotsumoto D, Sagara Y, Ohi Y, Oosako S, Sagara Y.
    Jpn J Radiol; 2018 Feb 01; 36(2):122-133. PubMed ID: 29159779
    [Abstract] [Full Text] [Related]

  • 53. Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI.
    Kirchner J, Grueneisen J, Martin O, Oehmigen M, Quick HH, Bittner AK, Hoffmann O, Ingenwerth M, Catalano OA, Heusch P, Buchbender C, Forsting M, Antoch G, Herrmann K, Umutlu L.
    Eur J Nucl Med Mol Imaging; 2018 Dec 01; 45(13):2328-2337. PubMed ID: 30056547
    [Abstract] [Full Text] [Related]

  • 54. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
    Schmidt GP, Baur-Melnyk A, Haug A, Utzschneider S, Becker CR, Tiling R, Reiser MF, Hermann KA.
    Eur Radiol; 2009 Jun 01; 19(6):1366-78. PubMed ID: 19190917
    [Abstract] [Full Text] [Related]

  • 55. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.
    Acta Radiol; 2015 Aug 01; 56(8):917-23. PubMed ID: 25013091
    [Abstract] [Full Text] [Related]

  • 56. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
    Ponisio MR, McConathy J, Laforest R, Khanna G.
    Pediatr Radiol; 2016 Aug 01; 46(9):1258-68. PubMed ID: 27003132
    [Abstract] [Full Text] [Related]

  • 57. Whole-body [¹⁸F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results.
    Beiderwellen K, Huebner M, Heusch P, Grueneisen J, Ruhlmann V, Nensa F, Kuehl H, Umutlu L, Rosenbaum-Krumme S, Lauenstein TC.
    Eur Radiol; 2014 Aug 01; 24(8):2023-30. PubMed ID: 24907940
    [Abstract] [Full Text] [Related]

  • 58. Comparison of Interobserver Agreement and Diagnostic Accuracy for IASLC/ITMIG Thymic Epithelial Tumor Staging Among Co-registered FDG-PET/MRI, Whole-body MRI, Integrated FDG-PET/CT, and Conventional Imaging Examination with and without Contrast Media Administrations.
    Ohno Y, Kishida Y, Seki S, Koyama H, Yui M, Aoyagi K, Yoshikawa T.
    Acad Radiol; 2022 Mar 01; 29 Suppl 3():S122-S131. PubMed ID: 29395795
    [Abstract] [Full Text] [Related]

  • 59. Journal Club: Diagnostic value of (18)F-FDG PET/CT and MRI in predicting the clinicopathologic subtypes of invasive breast cancer.
    Miyake KK, Nakamoto Y, Kanao S, Tanaka S, Sugie T, Mikami Y, Toi M, Togashi K.
    AJR Am J Roentgenol; 2014 Aug 01; 203(2):272-9. PubMed ID: 25055259
    [Abstract] [Full Text] [Related]

  • 60. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.
    Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, Deroose C, Souverijns G, Dymarkowski S, De Keyzer F, Vandecaveye V.
    Eur Radiol; 2014 Apr 01; 24(4):889-901. PubMed ID: 24322510
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.